Deborah M. Messemer, Director at Allogene Therapeutics, Inc. (ALLO), sold 18,641 shares at $2.28 ($43K) on 2024-06-18, disclosed to the SEC on 2024-06-20.
Scheduled sale ($43k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| PYPL | SELL | 2025-06-06 | $277K | — | Filing → |
| ALLO | SELL | 2025-02-20 | $32K | — | Filing → |
| TPG | SELL | 2025-01-15 | $210K | — | Filing → |